SCHEMBL1127197

SCHEMBL1127197

CCCC[Sn].[H-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10622467 1.00
SCHEMBL10482149 1.00
SCHEMBL29761 0.96
SCHEMBL11127109 0.96 TSHR (0.50)
SCHEMBL672984 0.96
Hydrochloric Acid SCHEMBL135075 0.92
Iodide SCHEMBL2584329 0.92
Hydrogen Sulfide SCHEMBL6874931 0.92 TSHR (0.46)
SCHEMBL6372546 0.92
Bromide SCHEMBL5897386 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323362-A1 METHODS OF PREPARING CARBANUCLEOSIDES USING AMIDES GILEAD SCIENCES, INC. (US) 2024-02-21 EP claimed
CN-112679512-A Tributine intermediate and preparation method thereof 南通诺泰生物医药技术有限公司 2021-04-20 CN claimed
EP-3081560-B1 TAXANES COMPOUNDS, PREPARATION METHOD THEREFOR, AND USES THEREOF JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD (CN) 2021-03-24 EP claimed
CN-110240590-A A kind of pyrimidine quinoline and its preparation method and application 广州新民培林医药科技有限公司 2019-09-17 CN claimed
US-10253007-B2 Taxanes compounds, preparation method therefor, and uses thereof JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2019-04-09 US claimed
WO-2019067139-A1 SELECTIVE REDUCTION OF CHLORODISILANES WITH TRI-N-BUTYL TIN HYDRIDE DOW SILICONES CORPORATION (US) 2019-04-04 WO claimed
CN-107089949-A A kind of organotin PVC stabilizer and preparation method thereof 毛龙飞 2017-08-25 CN claimed
CN-107033092-A The preparation method of the new organo-tin compound acted on PVC stabilizer 毛龙飞 2017-08-11 CN claimed
CN-107011276-A A kind of preparation method of new organotin PVC stabilizer 毛龙飞 2017-08-04 CN claimed
CN-106986836-A The preparation method of novel techykinin antagonist with antibacterial activity 毛阿龙 2017-07-28 CN claimed
CN-106966982-A 3,5 trifluoromethylbenzenes link 1H pyrazole compounds with antibacterial activity and its preparation method and application 毛龙飞 2017-07-21 CN claimed
CN-106478714-A A kind of Alkyzin compound or the preparation method of benzyl tin compound 北京大学 2017-03-08 CN claimed
EP-3081560-A1 TAXANES COMPOUNDS, PREPARATION METHOD THEREFOR, AND USES THEREOF Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (CN) 2016-10-19 EP claimed
US-20160297784-A1 Taxanes Compounds, Preparation Method Therefor, and Uses Thereof JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2016-10-13 US claimed
CN-104650012-A Taxane compound TASLY HOLDING GROUP CO LTD 2015-05-27 CN claimed
CN-101973917-B Method for catalyzing asymmetric Michael addition through alpha, beta-unsaturated ketone and sulfonyl compound and application thereof UNIV EAST CHINA SCIENCE & TECH 2015-03-04 CN claimed
WO-2006007917-A1 COMPOSITION OF FLUORINATED SILICONES, PARTICULARLY BUT NOT EXCLUSIVELY FOR ADHESIVE-RELEASING COATINGS, AND PREPARATION THEREOF MAFLON S.R.L. (IT) 2006-01-26 WO claimed
WO-2002072547-A1 AMINATION PROCESS ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) 2002-09-19 WO claimed
WO-2002070439-A2 AMINATION PROCESS JOHNSTON, JEFFREY, N. 2002-09-12 WO claimed
JP-6211890-A None JP disclosed
CN-115925675-B PSAMMAPLIN A derivatives, and preparation method and application thereof 中国海洋大学 2025-04-01 CN disclosed
CN-111132985-B Integrated process for the manufacture of methylchlorohydrosilane 莫门蒂夫性能材料股份有限公司 2024-01-02 CN disclosed
US-20230414771-A1 PREPARATION AND USE OF IMMUNOSTIMULATORY CONJUGATED COMPLEXES FOR TARGETED DELIVERY AND ACTIVATION YAFEI SHANGHAI BIOLOGY MEDICINE SCIENCE & TECHNOLOGY CO., LTD. (CN) 2023-12-28 US disclosed
EP-4165024-A1 CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS Amgen Inc. (US) 2023-04-19 EP disclosed
CN-115925675-A Psamaplin A derivative and preparation method and application thereof 中国海洋大学 2023-04-07 CN disclosed
CN-110997683-B Synthesis of 1, 1-trichlorosilane 南大光电半导体材料有限公司 2023-03-31 CN disclosed
EP-4108675-A1 PREPARATION AND USE OF IMMUNOSTIMULATORY COUPLING COMPLEX WHICH IS DELIVERED AND ACTIVATED IN TARGETED MANNER Yafei Shanghai Biolog Medicine Science & Technology Co., Ltd. (CN) 2022-12-28 EP disclosed
WO-2021252820-A1 CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS AMGEN INC. (US) 2021-12-16 WO disclosed
CN-111647000-B Pyrazine derivative and application thereof in inhibition of SHP2 勤浩医药(苏州)有限公司 2021-10-12 CN disclosed
CN-113474338-A Pyrazine derivative and application thereof in inhibition of SHP2 勤浩医药(苏州)有限公司 2021-10-01 CN disclosed
WO-2021108198-A1 INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-06-03 WO disclosed
EP-3081560-B1 TAXANES COMPOUNDS, PREPARATION METHOD THEREFOR, AND USES THEREOF JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD (CN) 2021-03-24 EP disclosed
EP-3072896-B1 TAXANE COMPOUND, AND PREPARATION METHOD AND USE THEREOF JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD (CN) 2021-01-06 EP disclosed
CN-111647000-A Pyrazine derivative and application thereof in inhibition of SHP2 勤浩医药(苏州)有限公司 2020-09-11 CN disclosed
CN-107417595-B Series monoterpene indole alkaloid skeleton based on free radical tandem reaction and synthetic method of natural product 四川大学 2020-07-24 CN disclosed
CN-110997683-A Synthesis of 1,1, 1-trichlorosilane 美国陶氏有机硅公司 2020-04-10 CN disclosed
CN-110240590-A A kind of pyrimidine quinoline and its preparation method and application 广州新民培林医药科技有限公司 2019-09-17 CN disclosed
US-10253007-B2 Taxanes compounds, preparation method therefor, and uses thereof JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2019-04-09 US disclosed
WO-2019067139-A1 SELECTIVE REDUCTION OF CHLORODISILANES WITH TRI-N-BUTYL TIN HYDRIDE DOW SILICONES CORPORATION (US) 2019-04-04 WO disclosed
CN-106478714-B A kind of preparation method of Alkyzin compound or benzyl tin compound 北京大学 2019-01-18 CN disclosed
CN-104650109-B Bearing taxanes 江苏天士力帝益药业有限公司 2019-01-01 CN disclosed
CN-108558806-A A kind of key intermediate and preparation method thereof of 5- oXo-tetrahydros pyrans -3- carboxylates 南京药石科技股份有限公司 2018-09-21 CN disclosed
CN-104926712-B Synthesize intermediate of VX-960 and preparation method thereof 上海医药工业研究院 2018-03-23 CN disclosed
US-9890175-B2 Taxane compound, and preparation method and use thereof JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2018-02-13 US disclosed
CN-107417595-A A kind of synthetic method of serial monoterpenoid indole alkaloid skeleton and natural products based on free radical cascade reaction 四川大学 2017-12-01 CN disclosed
CN-107260733-A The preparation method of new medicament for resisting platelet aggregation of the one kind containing 1,6 dihydropyridine 3 (2H) ketone structures 侯茜茜 2017-10-20 CN disclosed
CN-107089949-A A kind of organotin PVC stabilizer and preparation method thereof 毛龙飞 2017-08-25 CN disclosed
CN-107033092-A The preparation method of the new organo-tin compound acted on PVC stabilizer 毛龙飞 2017-08-11 CN disclosed
CN-107011276-A A kind of preparation method of new organotin PVC stabilizer 毛龙飞 2017-08-04 CN disclosed
CN-106986836-A The preparation method of novel techykinin antagonist with antibacterial activity 毛阿龙 2017-07-28 CN disclosed
CN-106966982-A 3,5 trifluoromethylbenzenes link 1H pyrazole compounds with antibacterial activity and its preparation method and application 毛龙飞 2017-07-21 CN disclosed
CN-106478714-A A kind of Alkyzin compound or the preparation method of benzyl tin compound 北京大学 2017-03-08 CN disclosed
CN-106478714-A A kind of Alkyzin compound or the preparation method of benzyl tin compound 北京大学 2017-03-08 CN disclosed
CN-106257976-A Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2016-12-28 CN disclosed
US-20160340365-A1 TAXANE COMPOUND, AND PREPARATION METHOD AND USE THEREOF JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2016-11-24 US disclosed
EP-3087077-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2016-11-02 EP disclosed
EP-3081560-A1 TAXANES COMPOUNDS, PREPARATION METHOD THEREFOR, AND USES THEREOF Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (CN) 2016-10-19 EP disclosed
US-20160297784-A1 Taxanes Compounds, Preparation Method Therefor, and Uses Thereof JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2016-10-13 US disclosed
EP-3072896-A1 TAXANE COMPOUND, AND PREPARATION METHOD AND USE THEREOF Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (CN) 2016-09-28 EP disclosed
CN-103354808-B Antiviral compound ABBVIE 公司 2016-08-10 CN disclosed
CN-105814062-A Spiro-oxazolones 豪夫迈·罗氏有限公司 2016-07-27 CN disclosed
CN-105793266-A Spiro-oxazolones 豪夫迈·罗氏有限公司 2016-07-20 CN disclosed
CN-105693788-A Preparation method of acetyl protection 2,6-dideoxy alpha-glucose glycol glycosides 华东师范大学 2016-06-22 CN disclosed
CN-102791693-B Hepatitis c virus inhibitors BRISTOL-MYERS SQUIBB CO. (US) 2016-04-13 CN disclosed
CN-102803227-B Morpholinyl quinazolines MERCK PATENT GMBH (DE) 2016-01-20 CN disclosed
CN-105228983-A The compound regulated for kinases and indication thereof PLEXXIKON INC 2016-01-06 CN disclosed
CN-105121454-A C-19 modified triterpenoids with HIV maturation inhibitory activity BRISTOL MYERS SQUIBB CO 2015-12-02 CN disclosed
CN-105121418-A Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection GILEAD SCIENCES INC 2015-12-02 CN disclosed
CN-105001165-A Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith SIGNAL PHARM LLC 2015-10-28 CN disclosed
CN-104926831-A Telaprevir synthesis intermediate and preparation method thereof SHANGHAI INST PHARM INDUSTRY 2015-09-23 CN disclosed
CN-104926712-A Telaprevir synthesis intermediate and preparation method thereof SHANGHAI INST PHARM INDUSTRY 2015-09-23 CN disclosed
CN-104903322-A Antibacterial oxadiazolone derivatives ACTELION PHARMACEUTICALS LTD 2015-09-09 CN disclosed
WO-2015096035-A1 INHIBITORS OF RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2015-07-02 WO disclosed
WO-2015100147-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2015-07-02 WO disclosed
CN-104650109-A Taxane compound TASLY HOLDING GROUP CO LTD 2015-05-27 CN disclosed
CN-104650012-A Taxane compound TASLY HOLDING GROUP CO LTD 2015-05-27 CN disclosed
CN-104540826-A Spiro-fused piperidine derivatives useful as inhibitors of extrarenal potassium channels MERCK SHARP & DOHME 2015-04-22 CN disclosed
CN-101973917-B Method for catalyzing asymmetric Michael addition through alpha, beta-unsaturated ketone and sulfonyl compound and application thereof UNIV EAST CHINA SCIENCE & TECH 2015-03-04 CN disclosed
CN-104292146-A Telaprevir intermediate and preparation method thereof SHANGHAI INST PHARM INDUSTRY 2015-01-21 CN disclosed
EP-2079844-B1 SYNTHESIS OF INIMERS AND HYPERBRANCHED POLYMERS UNIV AKRON (US) 2015-01-07 EP disclosed
EP-2699585-A1 PROCESSES FOR THE MANUFACTURE OF MACROCYCLIC DEPSIPEPTIDES AND NEW INTERMEDIATES Novartis AG (CH) 2014-02-26 EP disclosed
WO-2013167585-A2 RECYCLING OF ORGANOTIN COMPOUNDS UNIVERSITEIT ANTWERPEN (BE) 2013-11-14 WO disclosed
US-8524942-B2 Synthesis of inimers and hyperbranched polymers THE UNIVERSITY OF AKRON (US) 2013-09-03 US disclosed
US-8338450-B2 Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors LUPIN LIMITED (IN) 2012-12-25 US disclosed
WO-2012143888-A1 PROCESSES FOR THE MANUFACTURE OF MACROCYCLIC DEPSIPEPTIDES AND NEW INTERMEDIATES NOVARTIS AG (CH) 2012-10-26 WO disclosed
CN-102712646-A RAF inhibitor compounds and methods of use thereof ARRAY BIOPHARMA INC 2012-10-03 CN disclosed
WO-2012033298-A3 METHOD FOR MANUFACTURING A NOX GAS SENSOR, AND NOX GAS SENSOR MANUFACTURED USING SAME 일진머티리얼즈 주식회사 (KR) 2012-05-10 WO disclosed
EP-2006289-B1 PYRAZOLE-TYPE CYANINE DYE WAKO PURE CHEM IND LTD (JP) 2011-11-30 EP disclosed
US-20110144321-A1 SYNTHETIC INTERMEDIATES AND PROCESSES BIOCRYST PHARMACEUTICALS, INC. (US) 2011-06-16 US disclosed
EP-2313416-A2 SYNTHETIC INTERMEDIATES AND PROCESSES BIOCRYST PHARMACEUTICALS, INC. (US) 2011-04-27 EP disclosed
US-20110053856-A1 METABOLITE DERIVATIVES OF THE HDAC INHIBITOR FK228 GLOUCESTER PHARMACEUTICALS, INC. 2011-03-03 US disclosed
US-20110046334-A1 SYNTHESIS OF INIMERS AND HYPERBRANCHED POLYMERS THE UNIVERSITY OF AKRON (US) 2011-02-24 US disclosed
EP-2282636-A2 BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS GlaxoSmithKline LLC (US) 2011-02-16 EP disclosed
US-20100291020-A1 NOVEL COMPOUNDS AS DIPEPTIDYL PEPTIDASE IV (DPP IV) INHIBITORS LUPIN LIMITED (IN) 2010-11-18 US disclosed
US-7709469-B2 P2X7 receptor antagonists and methods of use ABBOTT LABORATORIES (US) 2010-05-04 US disclosed
US-7709636-B2 Pyrazole sulfonylurea compound and herbicide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-05-04 US disclosed
WO-2010011748-A2 SYNTHETIC INTERMEDIATES AND PROCESSES BIOCRYST PHARMACEUTICALS, INC. (US) 2010-01-28 WO disclosed
US-20100016584-A1 Pyrazole sulfonylurea compound and herbicide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-01-21 US disclosed
WO-2009137391-A2 BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2009-11-12 WO disclosed
EP-2079844-A1 SYNTHESIS OF INIMERS AND HYPERBRANCHED POLYMERS The University of Akron (US) 2009-07-22 EP disclosed
US-7557067-B2 Pyrazole sulfonylurea compound and herbicide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-07-07 US disclosed
WO-2009037719-A1 NOVEL COMPOUNDS AS DIPEPTIDYL PEPTIDASE IV (DPP IV) INHIBITORS LUPIN LIMITED (IN) 2009-03-26 WO disclosed
EP-2006289-A1 PYRAZOLE-TYPE CYANINE DYE Wako Pure Chemical Industries, Ltd. (JP) 2008-12-24 EP disclosed
EP-1951689-A1 P2X7 RECEPTOR ANTAGONISTS AND METHODS OF USE ABBOTT LABORATORIES (US) 2008-08-06 EP disclosed
EP-1924553-A1 BICYCLO[2.2.]HEPT-7-YLAMINE DERIVATIVES AND THEIR USES Argenta Discovery Limited (GB) 2008-05-28 EP disclosed
WO-2008045299-A1 SYNTHESIS OF INIMERS AND HYPERBRANCHED POLYMERS UNIVERSITY OF AKRON (US) 2008-04-17 WO disclosed
US-20080064600-A1 Pyrazole Sulfonylurea Compound and Herbicide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-03-13 US disclosed
US-20070265242-A1 Novel Carbapenem Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-11-15 US disclosed
US-20070129290-A1 Metabolite derivatives of the HDAC inhibitor FK228 GLOUCESTER PHARMACEUTICALS, INC. 2007-06-07 US disclosed
WO-2007056046-A1 P2X7 RECEPTOR ANTAGONISTS AND METHODS OF USE ABBOTT LABORATORIES (US) 2007-05-18 WO disclosed
EP-1785426-A1 NOVEL CARBAPENEM COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2007-05-16 EP disclosed
US-20070105842-A1 P2X7 receptor antagonists and methods of use ABBVIE INC. 2007-05-10 US disclosed
WO-2007017670-A1 BICYCLO[2.2.]HEPT-7-YLAMINE DERIVATIVES AND THEIR USES ARGENTA DISCOVERY LTD. (GB) 2007-02-15 WO disclosed
EP-1748047-A1 PYRAZOLE SULFONYLUREA COMPOUND AND HERBICIDE Nissan Chemical Industries, Ltd. (JP) 2007-01-31 EP disclosed
EP-1730165-A1 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE SCHERING CORPORATION (US) 2006-12-13 EP disclosed
EP-1684754-A1 HMG-COA REDUCTASE INHIBITORS AND METHOD Bristol-Myers Squibb Company (US) 2006-08-02 EP disclosed
EP-1626720-A1 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. Lundbeck A/S (DK) 2006-02-22 EP disclosed
WO-2006007917-A1 COMPOSITION OF FLUORINATED SILICONES, PARTICULARLY BUT NOT EXCLUSIVELY FOR ADHESIVE-RELEASING COATINGS, AND PREPARATION THEREOF MAFLON S.R.L. (IT) 2006-01-26 WO disclosed
WO-2005092907-A2 MONOSACCHARIDE DERIVATIVES AS ANTI-CANCER AND ANTI-INFLAMMATORY AGENTS RANBAXY LABORATORIES LIMITED (IN) 2005-10-06 WO disclosed
WO-2005085275-A1 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE SCHERING CORPORATION (US) 2005-09-15 WO disclosed
WO-2005051386-A1 HMG-COA REDUCTASE INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-09 WO disclosed
WO-2005048956-A2 ESTRADIOL-RELATED COMPOUNDS AND METHODS OF USE AS ANTI-TUMOR AGENTS UNIVERSITY OF MASSACHUSETTS (US) 2005-06-02 WO disclosed
EP-1467730-A1 NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-10-20 EP disclosed
WO-2004087156-A1 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. LUNDBECK A/S (DK) 2004-10-14 WO disclosed
WO-2003061651-A1 NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-07-31 WO disclosed
EP-1289966-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-03-12 EP disclosed
WO-2002072547-A1 AMINATION PROCESS ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) 2002-09-19 WO disclosed
WO-2002070439-A2 AMINATION PROCESS JOHNSTON, JEFFREY, N. 2002-09-12 WO disclosed
EP-1232166-A2 SYNTHESIS OF 2'-DEOXY-L-NUCLEOSIDES Pharmasset Limited (US) 2002-08-21 EP disclosed
EP-1204659-A2 SEROTONERGIC BENZOFURANS ELI LILLY AND COMPANY (US) 2002-05-15 EP disclosed
EP-1204660-A1 SEROTONERGIC BENZOTHIOPHENES ELI LILLY AND COMPANY (US) 2002-05-15 EP disclosed
EP-1202999-A1 NOVEL 2-DECARBOXY-2-PHOSPHINICO PROSTAGLANDIN F ANALOGS THE PROCTER & GAMBLE COMPANY (US) 2002-05-08 EP disclosed
EP-1007031-A4 4-CYANO-4-DEFORMYLSORDARIN DERIVATIVES MERCK & CO INC (US) 2001-10-24 EP disclosed
WO-2001077086-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION DUPONT PHARMACEUTICALS COMPANY (US) 2001-10-18 WO disclosed
WO-2001034618-A2 SYNTHESIS OF 2'-DEOXY-L-NUCLEOSIDES PHARMASSET LIMITED (US) 2001-05-17 WO disclosed
WO-2001010873-A1 NOVEL 2-DECARBOXY-2-PHOSPHINICO PROSTAGLANDIN F ANALOGS THE PROCTER & GAMBLE COMPANY (US) 2001-02-15 WO disclosed
WO-2001009126-A1 SEROTONERGIC BENZOTHIOPHENES ELI LILLY AND COMPANY (US) 2001-02-08 WO disclosed
WO-2001009122-A2 SEROTONERGIC BENZOFURANS ELI LILLY AND COMPANY (US) 2001-02-08 WO disclosed
EP-1007031-A1 4-CYANO-4-DEFORMYLSORDARIN DERIVATIVES Merck & Co., Inc. (US) 2000-06-14 EP disclosed
EP-1005445-A1 N-ALKANOYLPHENYLALANINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-07 EP disclosed
EP-1005446-A1 N-AROYLPHENYLALANINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-07 EP disclosed
EP-0915881-A1 PYRROLOAZEPINE COMPOUNDS SUNTORY LIMITED (JP) 1999-05-19 EP disclosed
WO-1999010313-A1 N-AROYLPHENYLALANINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 1999-03-04 WO disclosed
WO-1999010312-A1 N-ALKANOYLPHENYLALANINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-03-04 WO disclosed
WO-1999009974-A1 4-CYANO-4-DEFORMYLSORDARIN DERIVATIVES MERCK & CO., INC. (US) 1999-03-04 WO disclosed
WO-1998041527-A1 PYRROLOAZEPINE COMPOUNDS SUNTORY LIMITED (JP) 1998-09-24 WO disclosed
WO-1998005662-A1 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGS AS ANTIHERPETIC AGENTS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-02-12 WO disclosed
EP-0784628-A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1997-07-23 EP disclosed
CN-1151737-A 1, 2, 4, 6-thiatriazines with herbicidal activity CIBA GEIGY AG (CH) 1997-06-11 CN disclosed
EP-0737202-A1 HYPOCHOLESTEROLEMIC AGENTS PFIZER INC. (US) 1996-10-16 EP disclosed
EP-0737203-A1 STEROIDAL GLYCOSIDES PFIZER INC. (US) 1996-10-16 EP disclosed
US-5502073-A INSECTICIDES OR ANTHELMINTICS THE WELLCOME FOUNDATION (GB) 1996-03-26 US disclosed
WO-1995035308-A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-12-28 WO disclosed
WO-1995018143-A1 HYPOCHOLESTEROLEMIC AGENTS PFIZER INC. (US) 1995-07-06 WO disclosed
WO-1995018144-A1 STEROIDAL GLYCOSIDES PFIZER INC. (US) 1995-07-06 WO disclosed
EP-0346427-B1 MACROCYCLIC COMPOUNDS FISONS PLC (GB) 1995-03-29 EP disclosed
US-5376663-A Immunosuppressive agents; e.g. 1,14-Dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28,-dioxa-4-azatricyclo(22.3.1.04,9)octacos-18-ene-2,3,10,16-tetraone FISONS PLC (GB) 1994-12-27 US disclosed
JP-H06211890-A 2'-DEOXY-2'@(3754/24)S)-SUBSTITUTED ALKYLCYTIDINE DERIVATIVE YAMASA SHOYU CO LTD 1994-08-02 JP disclosed
EP-0607400-A1 Fluorinated 17-beta substituted-4-aza-5-alpha- andostran-3one derivatives. PHARMACIA &amp; UPJOHN S.p.A. (IT) 1994-07-27 EP disclosed
EP-0582338-A2 17-Spiromethylene steroids Akzo Nobel N.V. (NL) 1994-02-09 EP disclosed
US-5210227-A IMMUNOSUPPRESSIVE COMPOUNDS FISONS PLC (GB) 1993-05-11 US disclosed
US-5204330-A ANTIFUNGAL COMPOUNDS BEECHAM GROUP P.L.C. (GB) 1993-04-20 US disclosed
WO-1992015598-A1 PROCESS FOR THE DEOXYGENATION OF NUCLEOSIDES UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1992-09-17 WO disclosed
EP-0439556-A4 HETEROCYCLIC PEPTIDE RENIN INHIBITORS 1991-10-30 EP disclosed
EP-0444829-A2 Immunosuppressive compounds FISONS plc (GB) 1991-09-04 EP disclosed
EP-0439556-A1 HETEROCYCLIC PEPTIDE RENIN INHIBITORS ABBOTT LABORATORIES (US) 1991-08-07 EP disclosed
EP-0431870-A1 Amphotericin B derivatives Beecham Group p.l.c. (GB) 1991-06-12 EP disclosed
EP-0430579-A2 Fluoroaliphatic-group-substituted esters and method of making the same MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-06-05 EP disclosed
US-4937259-A Antihypercholesterolemic compounds MERCK & CO., INC. (US) 1990-06-26 US disclosed
WO-1990004917-A1 HETEROCYCLIC PEPTIDE RENIN INHIBITORS ABBOTT LABORATORIES (US) 1990-05-17 WO disclosed
US-4923867-A Synthetic marcfortine derivatives useful as antiparasitic agents MERCK & CO., INC. (US) 1990-05-08 US disclosed
EP-0346427-A1 MACROCYCLIC COMPOUNDS. FISONS PLC (GB) 1989-12-20 EP disclosed
WO-1989007102-A1 NULCEOSIDETYPE COMPOUNDS WHICH ARE PHOSPHODIESTERASE INHIBITORS SCHERING CORPORATION (US) 1989-08-10 WO disclosed
EP-0324562-A1 1-Carba(dethia)-3-cephem derivatives ELI LILLY AND COMPANY (US) 1989-07-19 EP disclosed
EP-0323042-A1 Process to macrocyclic compounds FISONS plc (GB) 1989-07-05 EP disclosed
WO-1989005304-A1 MACROCYCLIC COMPOUNDS FISONS PLC (GB) 1989-06-15 WO disclosed
EP-0294229-A2 Novel heterocyclic pesticidal compounds THE WELLCOME FOUNDATION LIMITED (GB) 1988-12-07 EP disclosed
EP-0074599-A1 5,6-cis-Carbapenem derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1983-03-23 EP disclosed
EP-0073451-A2 Carbapenam compound and processes for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-03-09 EP disclosed
EP-0001715-A2 Azetidinone antibiotics and their pharmaceutical formulations and use ELI LILLY AND COMPANY (US) 1979-05-02 EP disclosed
US-4087447-A Anti-secretory prostaglandins intermediates G. D. SEARLE & CO. (US) 1978-05-02 US disclosed
US-4087447-A Anti-secretory prostaglandins intermediates G. D. SEARLE & CO. (US) 1978-05-02 US disclosed